ask="N/A"
ask_size="N/A"
average_daily_volume="409193"
bid="6.75"
bid_size="10000"
book_value="3.69"
change="+0.35"
change_from_200_day_moving_average="-0.42"
change_from_50_day_moving_average="2.21"
change_from_52_week_high="-4.45"
change_From_52_week_low="6.09"
change_in_percent="+3.57%"
close="10.15"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-38.95M"
eps_estimate_current_year="-2.14"
eps_estimate_next_quarter="-0.51"
eps_estimate_next_year="-1.95"
ex_dividend_date="N/A"
float_shares="16088000"
high="10.29"
high_52_weeks="14.60"
last_trade_date="3/16/2017"
last_trade_price="10.15"
last_trade_size="8157"
last_trade_time="4:00pm"
low="9.68"
low_52_weeks="4.06"
market_capitalization="181.14M"
moving_average_200_day="10.57"
moving_average_50_day="7.94"
name="Stemline Therapeutics
Inc."
notes="N/A"
one_year_target_price="25.50"
open="9.80"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-3.96%"
percent_change_from_50_day_moving_average="+27.88%"
percent_change_from_52_week_high="-30.48%"
percent_change_from_52_week_low="+150.06%"
previous_close="9.80"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.66"
price_per_sales="184.56"
revenue="947604.00"
shares_outstanding="17846000"
short_ratio="1.67"
stock_exchange="NCM"
symbol="STML"
volume="249135"
weeks_range_52="4.06 - 14.60"
